In a recent study from Mass General Hospital, researchers examined whether information included in the medical record at the time of discharge after delivery could help us to identify individuals at increased risk for postpartum depression.
Postpartum anxiety is a common and often under-recognized condition that affects a substantial proportion of new mothers.
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on optimizing the likelihood of treatment for postpartum depression with Ob.Gyn News on August 27, 2024.
Blood levels of neuroactive steroids during the third trimester of pregnancy may predict increased risk of postpartum depression, offering possibility for early intervention.
Several studies suggest that screening during the first week postpartum may be helpful in identifying women at higher risk for experiencing postpartum depression.
Individuals with postpartum depression are being recruited for a clinical trial of a novel psychedelic compound, RE104.
There is little published data on the use of St. John's wort during breastfeeding and because we lack data, we would typically recommend using a conventional antidepressant, such as an SSRI or SNRI.Â
Further studies are needed to determine whether ketamine and esketamine are effective for the treatment of postpartum depression.
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on access to perinatal mental healthcare with Ob.Gyn News on May 23, 2024.
List of resources for families with infants in the Neonatal Intensive Care Unit.
